Notice of Availability

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )

Filed by the Registrant  x                            Filed by a Party other than the Registrant  ¨

Check the appropriate box:

 

¨ Preliminary Proxy Statement

 

¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

¨ Definitive Proxy Statement

 

x Definitive Additional Materials

 

¨ Soliciting Material Under Rule 14a-12

Harvard Bioscience, Inc.

 

Payment of Filing Fee (Check the appropriate box):

 

x No fee required.

 

¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

  (1) Title of each class of securities to which transaction applies:

      

 

  (2) Aggregate number of securities to which transaction applies:

      

 

  (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

      

 

  (4) Proposed maximum aggregate value of transaction:

      

 

  (5) Total fee paid:

      

 

 

¨ Fee paid previously with preliminary materials:

 

¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

  (1) Amount previously paid:

      

 

  (2) Form, Schedule or Registration Statement No.:

      

 

  (3) Filing Party:

      

 

  (4) Date Filed:

      

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareowner Meeting to Be Held on May 25, 2011

 

     

 

Meeting Information            

 

      Meeting Type:     Annual Meeting
   HARVARD BIOSCIENCE, INC.    For holders as of:     March 29, 2011
     

 

Date:      May 25, 2011

 

 

  Time: 11:00 AM EDT

      Location:    Burns & Levinson LLP
     

 125 Summer Street

     

 Boston, Massachusetts 02110

 

 

 

HARVARD BIOSCIENCE, INC.

84 OCTOBER HILL ROAD

HOLLISTON, MA 01746-1371

   

You are receiving this communication because you hold shares in the above named company.

 

    This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
   

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

    See the reverse side of this notice to obtain proxy materials and voting instructions.

0000103574_1    R1.0.0.11699


   

 

  Before You Vote 

    
            
        

How to Access the Proxy Materials

 

  Proxy Materials Available to VIEW or RECEIVE:    

 

  1. Notice & Proxy Statement            2. Annual Report

 

  How to View Online:

 

  Have the information that is printed in the box marked by the arrow LOGO (located on the following page)

  and visit: www.proxyvote.com.

 

  How to Request and Receive a PAPER or E-MAIL Copy:

 

  If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a

  copy. Please choose one of the following methods to make your request:

 

                                 1) BY INTERNET:         www.proxyvote.com

                                 2) BY TELEPHONE:     1-800-579-1639

                                 3) BY E-MAIL*:              sendmaterial@proxyvote.com

 

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 11, 2011 to facilitate timely delivery.

 

   

 

   

 

  How To Vote 

    
            
        

Please Choose One of the Following Voting Methods

 

          

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

        

0000103574_2    R1.0.0.11699


Voting Items      

 

The Board of Directors recommends you vote FOR the following:

     

 

1.       Election Of Directors

     

 

         Nominees:

     

         01  David Green

  

02     John F. Kennedy

  
     
The Board of Directors recommends you vote FOR proposals 2, 3 and 4:   

2.      To approve the Harvard Bioscience, Inc. Third Amended and Restated 2000 Stock Option and Incentive Plan to, among other things, increase the number of shares available for issuance thereunder by 3,700,000.

  

3.      To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2011.

  

4.      Approval, by a non-binding advisory vote, of the compensation of Harvard Bioscience, Inc.’s named executive officers.

  
The Board of Directors recommend you vote 1 YEAR on the following proposal:   

5.      Recommendation, by a non-binding advisory vote, of the frequency of the shareholder vote to approve the compensation of Harvard Bioscience, Inc.’s named executive officers.

  
NOTE: Such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.   

0000103574_3    R1.0.0.11699


 

 

 

0000103574_4    R1.0.0.11699